Feb. 8 Web Event: Americans’ Attitudes and Experiences with COVID-19 Vaccines: What We’ve Learned from the Vaccine Monitor

Since before the first COVID-19 vaccine became available more than a year ago, the KFF COVID-19 Vaccine Monitor Project has tracked the public’s evolving views about and experiences with the vaccines amid the ongoing pandemic.

On Feb. 8, 2022 KFF held a web briefing to share insights gleaned from nearly 40 Vaccine Monitor reports based on survey interviews with more than 24,000 people since December 2020. The conversation included:

  • Who remains unvaccinated and how has that changed over time?
  • What, if anything, might motivate vaccine holdouts to get a shot?
  • How have variants like delta and omicron affected people’s views and behaviors?
  • How motivated are people to get booster shots?
  • What can surveys tell us about equity in the vaccine effort, including across racial and ethnic groups?
  • How are parents approaching the decision of whether to vaccinate their children for COVID-19?
  • What is the role of misinformation in vaccine uptake?
  • How do different groups view vaccine mandates in different settings?
  • What role does partisan identification play in people’s experiences with the vaccine and views about the pandemic?
  • How might the pandemic affect politics and elections?

The briefing featured a presentation from the Vaccine Monitor research team, followed by a Q&A session with the online audience. Participants included:

  • Drew Altman, President and CEO
  • Mollyann Brodie, Executive Vice President and Executive Director of the Public Opinion and Survey Research Program
  • Liz Hamel, Vice President and Director of Public Opinion and Survey Research
  • Lunna Lopes, Senior Survey Analyst for Public Opinion and Survey Research

The KFF COVID-19 Vaccine Monitor is an ongoing research project tracking the public’s attitudes and experiences with COVID-19 vaccinations. Using a combination of surveys and qualitative research, this project tracks the dynamic nature of public opinion as vaccine development and distribution unfold, including vaccine confidence and hesitancy, trusted messengers and messages, as well as the public’s experiences with vaccination.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.